# Dermira

**Canonical:** https://apis.io/providers/dermira/  
**APIs profiled:** 0

Dermira was a biopharmaceutical company focused on medical dermatology, developing and commercializing treatments for chronic skin conditions such as primary axillary hyperhidrosis (Qbrexza / glycopyrronium) and atopic dermatitis (lebrikizumab). Headquartered in Menlo Park, California and originally backed by venture investors including Canaan Partners, the company went public on NASDAQ (DERM) in 2014 and was acquired by Eli Lilly and Company in 2020. Its assets and operations are now part of Eli Lilly; the dermira.com domain redirects to lilly.com. Dermira did not operate a public developer program, API, or developer portal, so this profile carries company identity only and has no API artifacts to enrich.

## Kin Score — 2.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 2.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 0.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biopharmaceutical, Pharmaceuticals, Dermatology, Healthcare, Life Sciences, Acquired

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/dermira/). Scores are computed from the provider's own public artifacts under a published rubric.